281 related articles for article (PubMed ID: 17466295)
21. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
22. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation.
Prévôt D; Voeltzel T; Birot AM; Morel AP; Rostan MC; Magaud JP; Corbo L
J Biol Chem; 2000 Jan; 275(1):147-53. PubMed ID: 10617598
[TBL] [Abstract][Full Text] [Related]
23. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
[TBL] [Abstract][Full Text] [Related]
24. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Page DM; DeFranco AL
J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
Yuniati L; van der Meer LT; Tijchon E; van Ingen Schenau D; van Emst L; Levers M; Palit SA; Rodenbach C; Poelmans G; Hoogerbrugge PM; Shan J; Kilberg MS; Scheijen B; van Leeuwen FN
Oncotarget; 2016 Jan; 7(3):3128-43. PubMed ID: 26657730
[TBL] [Abstract][Full Text] [Related]
26. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
27. hCAF1, a new regulator of PRMT1-dependent arginine methylation.
Robin-Lespinasse Y; Sentis S; Kolytcheff C; Rostan MC; Corbo L; Le Romancer M
J Cell Sci; 2007 Feb; 120(Pt 4):638-47. PubMed ID: 17264152
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of anti-proliferative protein BTG1 and BTG2.
Kim SH; Jung IR; Hwang SS
BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434
[TBL] [Abstract][Full Text] [Related]
29. A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death.
Kuss AW; Knödel M; Berberich-Siebelt F; Lindemann D; Schimpl A; Berberich I
Eur J Immunol; 1999 Oct; 29(10):3077-88. PubMed ID: 10540318
[TBL] [Abstract][Full Text] [Related]
30. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
Takada E; Hata K; Mizuguchi J
Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
[TBL] [Abstract][Full Text] [Related]
31. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
32. The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex.
Dolezal E; Infantino S; Drepper F; Börsig T; Singh A; Wossning T; Fiala GJ; Minguet S; Warscheid B; Tarlinton DM; Jumaa H; Medgyesi D; Reth M
Nat Immunol; 2017 Aug; 18(8):911-920. PubMed ID: 28628091
[TBL] [Abstract][Full Text] [Related]
33. PRMT1 and Btg2 regulates neurite outgrowth of Neuro2a cells.
Miyata S; Mori Y; Tohyama M
Neurosci Lett; 2008 Nov; 445(2):162-5. PubMed ID: 18773938
[TBL] [Abstract][Full Text] [Related]
34. Regulation of post-translational protein arginine methylation during HeLa cell cycle.
Kim C; Lim Y; Yoo BC; Won NH; Kim S; Kim G
Biochim Biophys Acta; 2010 Sep; 1800(9):977-85. PubMed ID: 20541591
[TBL] [Abstract][Full Text] [Related]
35. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
37. B-cell translocation gene 2: expression in the rat ovary and potential association with adenine nucleotide translocase 2 in mitochondria.
Park JI; Kim SG; Baek MW; Park TJ; Lim IK; Seo YW; Chun SY
Mol Cell Endocrinol; 2013 Mar; 367(1-2):31-40. PubMed ID: 23267836
[TBL] [Abstract][Full Text] [Related]
38. c-Jun NH2-terminal kinase (JNK)-dependent nuclear translocation of apoptosis-inducing factor (AIF) following engagement of membrane immunoglobulin on WEHI-231 B lymphoma cells.
Takada E; Hata K; Mizuguchi J
J Cell Biochem; 2008 Aug; 104(5):1927-36. PubMed ID: 18384124
[TBL] [Abstract][Full Text] [Related]
39. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
[TBL] [Abstract][Full Text] [Related]
40. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
Yi AK; Krieg AM
J Immunol; 1998 Feb; 160(3):1240-5. PubMed ID: 9570540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
